155 related articles for article (PubMed ID: 25391430)
1. Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.
Tas F; Yasasever CT; Karabulut S; Tastekin D; Duranyildiz D
Tumour Biol; 2015 Mar; 36(3):2097-103. PubMed ID: 25391430
[TBL] [Abstract][Full Text] [Related]
2. Serum transforming growth factor-beta 1 (TGF-β1) levels have diagnostic, predictive, and possible prognostic roles in patients with melanoma.
Tas F; Karabulut S; Yasasever CT; Duranyildiz D
Tumour Biol; 2014 Jul; 35(7):7233-7. PubMed ID: 24771267
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum transforming growth factor-beta 1 (TGF-β1) levels in patients with epithelial ovarian cancer.
Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D
Tumour Biol; 2014 Apr; 35(4):3611-6. PubMed ID: 24310505
[TBL] [Abstract][Full Text] [Related]
4. Circulating annexin A2 as a biomarker in gastric cancer patients: correlation with clinical variables.
Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D
Biomed Pharmacother; 2015 Feb; 69():237-41. PubMed ID: 25661364
[TBL] [Abstract][Full Text] [Related]
5. The significance of serum transforming growth factor beta 1 in detecting of gastric and colon cancers.
Coban S; Yüksel O; Koçkar MC; Köklü S; Basar O; Tutkak H; Ormeci N
Hepatogastroenterology; 2007; 54(77):1472-6. PubMed ID: 17708279
[TBL] [Abstract][Full Text] [Related]
6. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.
Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF
Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595
[TBL] [Abstract][Full Text] [Related]
7. Elevated circulating monocyte chemoattractant protein 1 (MCP-1/CCL-2) level may be an unfavorable predictive factor to platinum- and taxane-based combination chemotherapy in patients with gastric cancer.
Tas F; Karabulut S; Serilmez M; Karabulut M; Duranyildiz D
Cancer Chemother Pharmacol; 2016 Jan; 77(1):127-31. PubMed ID: 26499899
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of Serum Galectin-3 Levels in Gastric Cancer Patients.
Tas F; Bilgin E; Tastekin D; Erturk K; Duranyildiz D
J Gastrointest Cancer; 2016 Jun; 47(2):182-6. PubMed ID: 27038444
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of transforming growth factor beta1 are significantly correlated with venous invasion in patients with gastric cancer.
Lin Y; Kikuchi S; Obata Y; Yagyu K;
J Gastroenterol Hepatol; 2006 Feb; 21(2):432-7. PubMed ID: 16509870
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum epidermal growth factor receptor (EGFR) levels in patients with breast cancer.
Tas F; Bilgin E; Karabulut S; Duranyildiz D
Cytokine; 2015 Jan; 71(1):66-70. PubMed ID: 25259789
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of serum interleukin-18 (IL-18) levels in patients with gastric cancer.
Tas F; Tilgen Yasasever C; Karabulut S; Tastekin D; Duranyildiz D
Biomed Pharmacother; 2015 Mar; 70():19-23. PubMed ID: 25776473
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of serum transforming growth factor-β1 in lung cancer.
Hou YL; Chen H; Dong ZH; Xue CJ; Wu YF; Luo HX; Wu YC; Li CH
Cancer Epidemiol; 2013 Oct; 37(5):750-3. PubMed ID: 23727122
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: prognostic and predictive markers in triple-negative and non-triple-negative breast cancer.
Bahhnassy A; Mohanad M; Shaarawy S; Ismail MF; El-Bastawisy A; Ashmawy AM; Zekri AR
Mol Med Rep; 2015 Jul; 12(1):851-64. PubMed ID: 25824321
[TBL] [Abstract][Full Text] [Related]
15. High Serum Transforming Growth Factor-β1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib.
Lin TH; Shao YY; Chan SY; Huang CY; Hsu CH; Cheng AL
Clin Cancer Res; 2015 Aug; 21(16):3678-84. PubMed ID: 25977342
[TBL] [Abstract][Full Text] [Related]
16. Detection of transforming growth factor-alpha in the serum of gastric carcinoma patients.
Choi JH; Kim HC; Lim HY; Nam DK; Kim HS; Yi SY; Shim KS; Han WS
Oncology; 1999 Oct; 57(3):236-41. PubMed ID: 10545793
[TBL] [Abstract][Full Text] [Related]
17. Clinical and prognostic significance of serum transforming growth factor-beta1 levels in patients with pancreatic ductal adenocarcinoma.
Zhao J; Liang Y; Yin Q; Liu S; Wang Q; Tang Y; Cao C
Braz J Med Biol Res; 2016 Jul; 49(8):. PubMed ID: 27464025
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum level and gene polymorphisms of TGF-beta1 in gastric cancer.
Li X; Yue ZC; Zhang YY; Bai J; Meng XN; Geng JS; Fu SB
J Clin Lab Anal; 2008; 22(3):164-71. PubMed ID: 18484655
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of transforming growth factor beta1 in patients with breast cancer.
Sheen-Chen SM; Chen HS; Sheen CW; Eng HL; Chen WJ
Arch Surg; 2001 Aug; 136(8):937-40. PubMed ID: 11485532
[TBL] [Abstract][Full Text] [Related]
20. Examination of transforming growth factor beta1 expression in the serum and tumor tissue of gastric cancer.
Suda A; Saito N; Seshimo A; Kameoka S; Kobayashi M
Int Surg; 2009; 94(2):182-8. PubMed ID: 20108624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]